Merck & Co., Inc. Audio Webcast

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co., Inc. (NYSE: MRK):

  TO:   Journalists and Pharmaceutical Analysts
 
WHAT: Merck's 2010 R&D and Business Briefing
 
WHO: Richard T. Clark, chairman and CEO; Kenneth C. Frazier, president, Peter S. Kim, president Merck Research Laboratories; and other senior leaders.
 
WHEN: Tuesday, May 11, 2010, 8:30 a.m. to 1:00 p.m. ET
 
WEBCAST:

A live audio webcast will be available at: www.merck.com/investors

 
MEDIA KIT:

A virtual media kit will be available at: www.merck.com/newsroom/media-resource-center.html

 
REPLAY:

A replay of the webcast will be available starting on May 11 at: www.merck.com/investors.

 



CONTACT:

Merck & Co., Inc.
David Caouette, 908-423-3461
Global Media Relations
or
Alex Kelly, 908-423-5185
Investor Relations

KEYWORDS:   United States  North America  New Jersey

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.